Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis

QR Code

Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis

Background/Aims Proton pump inhibitors (PPIs) are widely used to treat several acid-related gastrointestinal disorders. This study aimed to investigate the risk of dementia in patients taking PPIs. Materials and Methods A systematic review was conducted to evaluate the correlation between PPIs and d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kyu-Tae Yoon, Chang Seok Bang, Joon Sung Kim
Format:	Article
Language:	English
Published:	Korean College of Helicobacter and Upper Gastrointestinal Research 2021-06-01
Series:	The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:	alzheimer disease dementia proton pump inhibitors
Online Access:	http://www.helicojournal.org/upload/pdf/kjhugr-2020-0057.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
by: Tae Jun Kim, et al.
Published: (2020-09-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)

The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)

Is It More Effective to Prescribe a Proton Pump Inhibitor Separately before a Meal for the Eradication of Helicobacter pylori?
by: Gyu Won Lee, et al.
Published: (2018-06-01)

METHOTREXATE AND PROTON PUMP INHIBITORS: ARE THERE ANY NEGATIVE PHARMACOLOGIAL EFFECTS?
by: Andrey E Karateev, et al.
Published: (2014-02-01)

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors
by: Maxwell Rossip, et al.
Published: (2025-06-01)

Genotoxicity in Patients on Long-term Proton Pump Inhibitor Therapy in Korea: A Nested Case-control, Prospective, Pilot Study
by: Youn I Choi, et al.
Published: (2020-03-01)

EARLY PARENTERAL USE OF PROTON PUMP INHIBITORS IN THE COMPLEx TREATMENT OF ACUTE POISONING WITH CAUTERANT AGENTS
by: K. K. Ilyashenko, et al.
Published: (2016-03-01)

СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS
by: Yu. V. Muravyev, et al.
Published: (2018-11-01)

Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women
by: Ahmed I. Soliman, et al.
Published: (2025-07-01)

The choice of proton pump inhibitor from the standpoint of efficacy and safety in a particular patient
by: E. A. Lyalukova, et al.
Published: (2021-06-01)

Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
by: O. D. Ostroumova, et al.
Published: (2019-11-01)

Current management of proton pump inhibitor-refractory gastroesophageal reflux disease
by: V. V. Tsukanov, et al.
Published: (2020-06-01)

Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023-11-01)

Standard First-line Triple Therapy for Helicobacter pylori Infection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors
by: Seong Ju Lee, et al.
Published: (2018-06-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

Risk of Bacterial Infection from Proton Pump Inhibitor Use
by: Sung Soo Kim, et al.
Published: (2017-06-01)

Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
by: V. T. Ivashkin, et al.
Published: (2020-12-01)

Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01)

Proton Pump Inhibitor Switching Strategy after Failure of Standard Triple Therapy for Infection
by: Jaeyoung Kim, et al.
Published: (2020-06-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)

Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study
by: Jingkai Di, et al.
Published: (2025-07-01)

Six stabs in the back of proton pump inhibitors
by: Andrei Evgenyevich Karateev
Published: (2013-06-01)

Proton Pump Inhibitors in the COVID-19 Pandemic
by: T. E. Kugler, et al.
Published: (2022-08-01)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017-12-01)

Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings
by: M. A. Evseyev, et al.
Published: (2010-06-01)

How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
by: Yu. V. Evsyutina
Published: (2023-06-01)

Gastric Corpus Hypertrophy with a Bleeding Hyperplastic Polyp in a -naive Subject after Long-term Proton Pump Inhibitor Use
by: Jong Hyeon Jeong, et al.
Published: (2022-03-01)

Gastroesophageal reflux disease in a comorbid patient, refractory to proton pump inhibitors. How can we help?
by: I. G. Pakhomova
Published: (2024-11-01)

Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction
by: Ya. G. Bozhko, et al.
Published: (2020-01-01)

Proton Pump Inhibitor Use Following Esophageal Variceal Ligation and Its Impact on Clinical Outcomes: Real-World Data from the TriNetX Global Collaborative Network
by: Nisar Amin, et al.
Published: (2025-06-01)

Impact of Biologics and Proton Pump Inhibitors on Gastrointestinal Infection Risk in Inflammatory Bowel Disease Patients: A Retrospective Analysis of Pathogen-Specific Outcomes and Treatment Interactions
by: Ryan Njeim, et al.
Published: (2025-07-01)

The Effect of Combined Therapy with a Proton Pump Inhibitor and Rebamipide on the Clinical Course and Morphofunctional Changes of the Esophageal Mucosa in Patients with Non-Erosive Reflux Disease
by: A. A. Makushina, et al.
Published: (2025-06-01)

Dementia in People With Multiple Sclerosis: A Systematic Review and Meta‐Analysis
by: Omid Mirmosayyeb, et al.
Published: (2025-06-01)

Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density
by: Hend Smaoui, et al.
Published: (2024-12-01)

Role of Gastric Acid Suppression Therapy in Erosive Esophagitis: From H2 Receptor Antagonists, Proton Pump Inhibitors, to Potassium-Competitive Acid Blockers
by: Ryan Herardi, et al.
Published: (2025-07-01)

Liver enzyme and risk of vascular dementia: A univariable and multivariable Mendelian randomization of European descent
by: Jieyu Chen, et al.
Published: (2024-12-01)